71 related articles for article (PubMed ID: 9704000)
21. Aberrant splicing but not mutations of TSG101 in human breast cancer.
Lee MP; Feinberg AP
Cancer Res; 1997 Aug; 57(15):3131-4. PubMed ID: 9242438
[TBL] [Abstract][Full Text] [Related]
22. Aberrant TSG101 transcripts in acute myeloid leukaemia.
Lin PM; Liu TC; Chang JG; Chen TP; Lin SF
Br J Haematol; 1998 Aug; 102(3):753-8. PubMed ID: 9722303
[TBL] [Abstract][Full Text] [Related]
23. Identification of novel first exons in Ad4BP/SF-1 (NR5A1) gene and their tissue- and species-specific usage.
Kimura R; Yoshii H; Nomura M; Kotomura N; Mukai T; Ishihara S; Ohba K; Yanase T; Gotoh O; Nawata H; Morohashi K
Biochem Biophys Res Commun; 2000 Nov; 278(1):63-71. PubMed ID: 11071856
[TBL] [Abstract][Full Text] [Related]
24. Expression of truncated FHIT transcripts in cervical cancers and in normal human cells.
Matthews CP; Shera K; Kiviat N; McDougall JK
Oncogene; 2001 Aug; 20(34):4665-75. PubMed ID: 11498789
[TBL] [Abstract][Full Text] [Related]
25. Low frequency of TSG101/CC2 gene alterations in invasive human breast cancers.
Wang Q; Driouch K; Courtois S; Champème MH; Bièche I; Treilleux I; Briffod M; Rimokh R; Magaud JP; Curmi P; Lidereau R; Puisieux A
Oncogene; 1998 Feb; 16(5):677-9. PubMed ID: 9482115
[TBL] [Abstract][Full Text] [Related]
26. Analysis of TSG101 tumour susceptibility gene transcripts in cervical and endometrial cancers.
Chang JG; Su TH; Wei HJ; Wang JC; Chen YJ; Chang CP; Jeng CJ
Br J Cancer; 1999 Feb; 79(3-4):445-50. PubMed ID: 10027311
[TBL] [Abstract][Full Text] [Related]
27. Differential expression and splicing isoform analysis of human Tcf-4 transcription factor in brain tumors.
Howng SL; Huang FH; Hwang SL; Lieu AS; Sy WD; Wang C; Hong YR
Int J Oncol; 2004 Dec; 25(6):1685-92. PubMed ID: 15547706
[TBL] [Abstract][Full Text] [Related]
28. Human transcription factor Sp3: genomic structure, identification of a processed pseudogene, and transcript analysis.
Moran KM; Crusio RH; Chan CH; Grekova MC; Richert JR
Gene; 2004 Oct; 341():235-47. PubMed ID: 15474306
[TBL] [Abstract][Full Text] [Related]
29. TSG101 expression in gynecological tumors: relationship to cyclin D1, cyclin E, p53 and p16 proteins.
Bennett NA; Pattillo RA; Lin RS; Hsieh CY; Murphy T; Lyn D
Cell Mol Biol (Noisy-le-grand); 2001 Nov; 47(7):1187-93. PubMed ID: 11838966
[TBL] [Abstract][Full Text] [Related]
30. Truncated TSG101 transcripts are present in peripheral blood from both familial breast cancer patients and controls.
Xu CF; Greenman J; Solomon E
Eur J Cancer; 1998 Jun; 34(7):1077-80. PubMed ID: 9849457
[TBL] [Abstract][Full Text] [Related]
31. TSG101 protein steady-state level is regulated posttranslationally by an evolutionarily conserved COOH-terminal sequence.
Feng GH; Lih CJ; Cohen SN
Cancer Res; 2000 Mar; 60(6):1736-41. PubMed ID: 10749147
[TBL] [Abstract][Full Text] [Related]
32. Identification of various exon combinations of the ews/fli1 translocation: an optimized RT-PCR method for paraffin embedded tissue -- a report by the CWS-study group.
Stegmaier S; Leuschner I; Aakcha-Rudel E; Münch P; Kazanowska B; Bekassy A; Treuner J; Koscielniak E
Klin Padiatr; 2004; 216(6):315-22. PubMed ID: 15565546
[TBL] [Abstract][Full Text] [Related]
33. Aberrant splicing of FHIT transcripts in human gastric cancer cell lines.
Lee SH; Kim HY; Kim TJ; Park HK; Kim WH; Woo KM; Cho MH
Res Commun Mol Pathol Pharmacol; 2002; 112(1-4):39-49. PubMed ID: 15080495
[TBL] [Abstract][Full Text] [Related]
34. Frequent abnormalities of TSG101 transcripts in human prostate cancer.
Sun Z; Pan J; Bubley G; Balk SP
Oncogene; 1997 Dec; 15(25):3121-5. PubMed ID: 9444960
[TBL] [Abstract][Full Text] [Related]
35. Analysis of aberrant transcription of TSG101 in hepatocellular carcinomas.
Chen YJ; Chen PH; Lin SY; Chang JG
Eur J Cancer; 1999 Feb; 35(2):302-8. PubMed ID: 10448275
[TBL] [Abstract][Full Text] [Related]
36. Characterization of the mouse matrilin-4 gene: a 5' antiparallel overlap with the gene encoding the transcription factor RBP-l.
Wagener R; Kobbe B; Aszódi A; Aeschlimann D; Paulsson M
Genomics; 2001 Aug; 76(1-3):89-98. PubMed ID: 11549321
[TBL] [Abstract][Full Text] [Related]
37. Clinical implications of aberrant TSG101 transcripts in acute myeloblastic leukemia.
Lin SF; Lin PM; Liu TC; Chang JG; Sue YC; Chen TP
Leuk Lymphoma; 2000 Feb; 36(5-6):463-6. PubMed ID: 10784390
[TBL] [Abstract][Full Text] [Related]
38. Significant increase of a specific variant TSG101 transcript during the progression of cervical neoplasia.
Klaes R; Kloor M; Willeke F; Melsheimer P; von Knebel Doeberitz M; Ridder R
Eur J Cancer; 1999 May; 35(5):733-7. PubMed ID: 10505033
[TBL] [Abstract][Full Text] [Related]
39. Reverse transcriptase template switching during reverse transcriptase-polymerase chain reaction: artificial generation of deletions in ribonucleotide reductase mRNA.
Mader RM; Schmidt WM; Sedivy R; Rizovski B; Braun J; Kalipciyan M; Exner M; Steger GG; Mueller MW
J Lab Clin Med; 2001 Jun; 137(6):422-8. PubMed ID: 11385363
[TBL] [Abstract][Full Text] [Related]
40. A splice variant of the neuron-restrictive silencer factor repressor is expressed in small cell lung cancer: a potential role in derepression of neuroendocrine genes and a useful clinical marker.
Coulson JM; Edgson JL; Woll PJ; Quinn JP
Cancer Res; 2000 Apr; 60(7):1840-4. PubMed ID: 10766169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
